| __timestamp | Ionis Pharmaceuticals, Inc. | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 14097000000 |
| Thursday, January 1, 2015 | 37173000 | 14809000000 |
| Friday, January 1, 2016 | 48616000 | 14837000000 |
| Sunday, January 1, 2017 | 108488000 | 14784000000 |
| Monday, January 1, 2018 | 244622000 | 14455000000 |
| Tuesday, January 1, 2019 | 287000000 | 14350000000 |
| Wednesday, January 1, 2020 | 354000000 | 11615000000 |
| Friday, January 1, 2021 | 186000000 | 12703000000 |
| Saturday, January 1, 2022 | 151000000 | 13677000000 |
| Sunday, January 1, 2023 | 232600000 | 14771000000 |
| Monday, January 1, 2024 | 267474000 | 14730000000 |
Unleashing insights
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. From 2014 to 2023, Pfizer Inc. and Ionis Pharmaceuticals, Inc. have taken distinct paths in optimizing these costs. Pfizer, a global leader, consistently reported SG&A expenses around $14 billion annually, reflecting its expansive operations. In contrast, Ionis Pharmaceuticals, a smaller entity, showed a more dynamic trend, with expenses peaking at $354 million in 2020, a 17-fold increase from 2014. This disparity highlights the scale and strategic differences between the two companies. While Pfizer's expenses remained stable, Ionis's fluctuated, indicating potential strategic shifts or investments. Understanding these trends offers insights into how each company navigates financial management in a rapidly evolving industry.
Pfizer Inc. and Viatris Inc.: SG&A Spending Patterns Compared
Pfizer Inc. and Sarepta Therapeutics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Walgreens Boots Alliance, Inc.
Comparing SG&A Expenses: Pfizer Inc. vs Cytokinetics, Incorporated Trends and Insights
Operational Costs Compared: SG&A Analysis of Pfizer Inc. and Vericel Corporation
Pfizer Inc. or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Alnylam Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc.
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
Ionis Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and MorphoSys AG
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.